A Registry Study on the Action of Controlling Ambulatory Blood Pressure to Target in Ten Thousand Patients

Status: Recruiting
Location: See location...
Study Type: Observational
SUMMARY

24 hour ambulatory blood pressure (ABP) monitoring should be the first choice for diagnosis and treatment of hypertension according to European Societyof Hypertension (ESH) and the European Society of Cardiology (ESC) guideline on ambulatory blood pressure monitoring. Finally, we should promote the clinical application of 24 hour ambulatory blood pressure monitoring to greatly improve the management level of hypertension in China and effectively reduce the risk caused by hypertension in the population. Information of hypertensive patients with ambulatory blood pressure monitoring was prospectively registered nationwide,and then to investigate whether there was difference in cardiovascular prognosis according to the control of ABP.

Eligibility
Participation Requirements
Sex: All
Minimum Age: 18
Maximum Age: 80
Healthy Volunteers: f
View:

• Age 18-80 years old

• Clinical diagnosed hypertension with the use of antihypertensive drugs

• A 24-hour ambulatory blood pressure monitoring was performed with validated equipment.

• Willing to provide information about disease history and blood biochemical test data within 6 months.

• Sign the informed consent

Locations
Other Locations
China
Ruijin Hospital
RECRUITING
Shanghai
Contact Information
Primary
Yan Li, Professor
liyanshcn@yahoo.com
021-64370045
Time Frame
Start Date: 2018-07-18
Estimated Completion Date: 2026-12-30
Participants
Target number of participants: 10000
Authors
Related Therapeutic Areas
Sponsors
Leads: Yan Li

This content was sourced from clinicaltrials.gov